Parallel Advisors’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.45K | Buy |
699
+189
| +37% | +$1.74K | ﹤0.01% | 2623 |
|
|
2025
Q1 | $4.38K | Hold |
510
| – | – | ﹤0.01% | 2714 |
|
|
2024
Q4 | $5.48K | Buy |
510
+260
| +104% | +$2.79K | ﹤0.01% | 2585 |
|
|
2024
Q3 | $1.42K | Hold |
250
| – | – | ﹤0.01% | 2946 |
|
|
2024
Q2 | $1.06K | Buy |
+250
| New | +$1.06K | ﹤0.01% | 2927 |
|
|
2022
Q2 | – | Sell |
-17
| Closed | – | – | 2975 |
|
|
2022
Q1 | $0 | Sell |
17
-78
| -82% | – | ﹤0.01% | 2954 |
|
|
2021
Q4 | $2K | Buy |
95
+16
| +20% | +$337 | ﹤0.01% | 2650 |
|
|
2021
Q3 | $1K | Hold |
79
| – | – | ﹤0.01% | 2782 |
|
|
2021
Q2 | $2K | Buy |
+79
| New | +$2K | ﹤0.01% | 2503 |
|
|
2017
Q2 | – | Sell |
-3,000
| Closed | -$17K | – | 2097 |
|
|
2017
Q1 | $17K | Buy |
+3,000
| New | +$17K | ﹤0.01% | 1011 |
|